カテゴリー： QYResearch, 世界

世界のがんヤヌスキナーゼ阻害剤市場

◆英語タイトル：Global Cancer Janus Kinase Inhibitor Market Professional Survey Report 2019
◆商品コード：DATA909X04991
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：112
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、がんヤヌスキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モメロチニブ、レスタウルチニブ、パクリチニブに、用途別には、肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、大腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫、その他にセグメント区分し、がんヤヌスキナーゼ阻害剤の世界市場を分析しました。

・エグゼクティブ・サマリー
・がんヤヌスキナーゼ阻害剤の世界市場概要
・がんヤヌスキナーゼ阻害剤の製造コスト構成分析
・がんヤヌスキナーゼ阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・がんヤヌスキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・がんヤヌスキナーゼ阻害剤のセグメント分析（種類別）
（モメロチニブ、レスタウルチニブ、パクリチニブ）
・がんヤヌスキナーゼ阻害剤のセグメント分析（用途別）
（肺がん、卵巣がん、乳がん、膵臓がん、肝細胞がん、大腸がん、頭頸部扁平上皮がん、前立腺がん、膠芽腫、その他）
・がんヤヌスキナーゼ阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abbott Laboratories、Asana Biosciences、Astra Zeneca、Celon Pharmaceuticals、Dynamic Pharma、Eli Lilly、Gilead Sciences、Hanmi Pharmaceuticals、Incyte、Kyowa Hakko、Moleculin、Pfizer、）
・がんヤヌスキナーゼ阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Cancer Janus Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cancer Janus Kinase Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Janus Kinase Inhibitor market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Janus Kinase Inhibitor in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cancer Janus Kinase Inhibitor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abbott Laboratories
Asana Biosciences
Astra Zeneca
Celon Pharmaceuticals
Dynamic Pharma
Eli Lilly
Gilead Sciences
Hanmi Pharmaceuticals
Incyte
Kyowa Hakko
Moleculin
Pfizer

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Momelotinib
Lestaurtinib
Pacritinib

Segment by Application
Lung Cancer
Ovarian Cancer
Breast Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Colorectal cancer
Head & Neck Squamous Cell Carcinoma
Prostate Cancer
Glioblastoma
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Cancer Janus Kinase Inhibitor
1.1 Definition of Cancer Janus Kinase Inhibitor
1.2 Cancer Janus Kinase Inhibitor Segment by Type
1.2.1 Global Cancer Janus Kinase Inhibitor Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Momelotinib
1.2.3 Lestaurtinib
1.2.4 Pacritinib
1.3 Cancer Janus Kinase Inhibitor Segment by Applications
1.3.1 Global Cancer Janus Kinase Inhibitor Consumption Comparison by Applications (2014-2025)
1.3.2 Lung Cancer
1.3.3 Ovarian Cancer
1.3.4 Breast Cancer
1.3.5 Pancreatic Cancer
1.3.6 Hepatocellular Carcinoma
1.3.7 Colorectal cancer
1.3.8 Head & Neck Squamous Cell Carcinoma
1.3.9 Prostate Cancer
1.3.10 Glioblastoma
1.3.11 Other
1.4 Global Cancer Janus Kinase Inhibitor Overall Market
1.4.1 Global Cancer Janus Kinase Inhibitor Revenue (2014-2025)
1.4.2 Global Cancer Janus Kinase Inhibitor Production (2014-2025)
1.4.3 North America Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)
1.4.4 Europe Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)
1.4.5 China Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)
1.4.6 Japan Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)
1.4.7 Southeast Asia Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)
1.4.8 India Cancer Janus Kinase Inhibitor Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Cancer Janus Kinase Inhibitor
2.3 Manufacturing Process Analysis of Cancer Janus Kinase Inhibitor
2.4 Industry Chain Structure of Cancer Janus Kinase Inhibitor

3 Development and Manufacturing Plants Analysis of Cancer Janus Kinase Inhibitor
3.1 Capacity and Commercial Production Date
3.2 Global Cancer Janus Kinase Inhibitor Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Cancer Janus Kinase Inhibitor
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Cancer Janus Kinase Inhibitor Production and Capacity Analysis
4.2 Cancer Janus Kinase Inhibitor Revenue Analysis
4.3 Cancer Janus Kinase Inhibitor Price Analysis
4.4 Market Concentration Degree

5 Cancer Janus Kinase Inhibitor Regional Market Analysis
5.1 Cancer Janus Kinase Inhibitor Production by Regions
5.1.1 Global Cancer Janus Kinase Inhibitor Production by Regions
5.1.2 Global Cancer Janus Kinase Inhibitor Revenue by Regions
5.2 Cancer Janus Kinase Inhibitor Consumption by Regions
5.3 North America Cancer Janus Kinase Inhibitor Market Analysis
5.3.1 North America Cancer Janus Kinase Inhibitor Production
5.3.2 North America Cancer Janus Kinase Inhibitor Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Cancer Janus Kinase Inhibitor Import and Export
5.4 Europe Cancer Janus Kinase Inhibitor Market Analysis
5.4.1 Europe Cancer Janus Kinase Inhibitor Production
5.4.2 Europe Cancer Janus Kinase Inhibitor Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Cancer Janus Kinase Inhibitor Import and Export
5.5 China Cancer Janus Kinase Inhibitor Market Analysis
5.5.1 China Cancer Janus Kinase Inhibitor Production
5.5.2 China Cancer Janus Kinase Inhibitor Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Cancer Janus Kinase Inhibitor Import and Export
5.6 Japan Cancer Janus Kinase Inhibitor Market Analysis
5.6.1 Japan Cancer Janus Kinase Inhibitor Production
5.6.2 Japan Cancer Janus Kinase Inhibitor Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Cancer Janus Kinase Inhibitor Import and Export
5.7 Southeast Asia Cancer Janus Kinase Inhibitor Market Analysis
5.7.1 Southeast Asia Cancer Janus Kinase Inhibitor Production
5.7.2 Southeast Asia Cancer Janus Kinase Inhibitor Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Cancer Janus Kinase Inhibitor Import and Export
5.8 India Cancer Janus Kinase Inhibitor Market Analysis
5.8.1 India Cancer Janus Kinase Inhibitor Production
5.8.2 India Cancer Janus Kinase Inhibitor Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Cancer Janus Kinase Inhibitor Import and Export

6 Cancer Janus Kinase Inhibitor Segment Market Analysis (by Type)
6.1 Global Cancer Janus Kinase Inhibitor Production by Type
6.2 Global Cancer Janus Kinase Inhibitor Revenue by Type
6.3 Cancer Janus Kinase Inhibitor Price by Type

7 Cancer Janus Kinase Inhibitor Segment Market Analysis (by Application)
7.1 Global Cancer Janus Kinase Inhibitor Consumption by Application
7.2 Global Cancer Janus Kinase Inhibitor Consumption Market Share by Application (2014-2019)

8 Cancer Janus Kinase Inhibitor Major Manufacturers Analysis
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.1.2 Abbott Laboratories Product Introduction, Application and Specification
8.1.3 Abbott Laboratories Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Asana Biosciences
8.2.1 Asana Biosciences Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.2.2 Asana Biosciences Product Introduction, Application and Specification
8.2.3 Asana Biosciences Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Astra Zeneca
8.3.1 Astra Zeneca Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.3.2 Astra Zeneca Product Introduction, Application and Specification
8.3.3 Astra Zeneca Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celon Pharmaceuticals
8.4.1 Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.4.2 Celon Pharmaceuticals Product Introduction, Application and Specification
8.4.3 Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Dynamic Pharma
8.5.1 Dynamic Pharma Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.5.2 Dynamic Pharma Product Introduction, Application and Specification
8.5.3 Dynamic Pharma Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Eli Lilly
8.6.1 Eli Lilly Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.6.2 Eli Lilly Product Introduction, Application and Specification
8.6.3 Eli Lilly Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Gilead Sciences
8.7.1 Gilead Sciences Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.7.2 Gilead Sciences Product Introduction, Application and Specification
8.7.3 Gilead Sciences Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Hanmi Pharmaceuticals
8.8.1 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.8.2 Hanmi Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Incyte
8.9.1 Incyte Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.9.2 Incyte Product Introduction, Application and Specification
8.9.3 Incyte Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Kyowa Hakko
8.10.1 Kyowa Hakko Cancer Janus Kinase Inhibitor Production Sites and Area Served
8.10.2 Kyowa Hakko Product Introduction, Application and Specification
8.10.3 Kyowa Hakko Cancer Janus Kinase Inhibitor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Moleculin
8.12 Pfizer

9 Development Trend of Analysis of Cancer Janus Kinase Inhibitor Market
9.1 Global Cancer Janus Kinase Inhibitor Market Trend Analysis
9.1.1 Global Cancer Janus Kinase Inhibitor Market Size (Volume and Value) Forecast 2019-2025
9.2 Cancer Janus Kinase Inhibitor Regional Market Trend
9.2.1 North America Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.2.2 Europe Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.2.3 China Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.2.4 Japan Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.2.5 Southeast Asia Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.2.6 India Cancer Janus Kinase Inhibitor Forecast 2019-2025
9.3 Cancer Janus Kinase Inhibitor Market Trend (Product Type)
9.4 Cancer Janus Kinase Inhibitor Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Cancer Janus Kinase Inhibitor Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Cancer Janus Kinase Inhibitor
Table Global Cancer Janus Kinase Inhibitor Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Cancer Janus Kinase Inhibitor Production Market Share by Types in 2018
Figure Momelotinib Product Picture
Figure Lestaurtinib Product Picture
Figure Pacritinib Product Picture
Table Global Cancer Janus Kinase Inhibitor Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Cancer Janus Kinase Inhibitor Consumption Market Share by Applications in 2018
Figure Lung Cancer
Figure Ovarian Cancer
Figure Breast Cancer
Figure Pancreatic Cancer
Figure Hepatocellular Carcinoma
Figure Colorectal cancer
Figure Head & Neck Squamous Cell Carcinoma
Figure Prostate Cancer
Figure Glioblastoma
Figure Other
Figure Global Cancer Janus Kinase Inhibitor Revenue (Million USD) (2014-2025)
Figure Global Cancer Janus Kinase Inhibitor Production (K Pcs) (2014-2025)
Figure North America Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Figure Europe Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Figure China Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Figure Japan Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Figure Southeast Asia Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Figure India Cancer Janus Kinase Inhibitor Market Size (Million USD) (2014-2025)
Table Cancer Janus Kinase Inhibitor Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Cancer Janus Kinase Inhibitor in 2018
Figure Manufacturing Process Analysis of Cancer Janus Kinase Inhibitor
Figure Industry Chain Structure of Cancer Janus Kinase Inhibitor
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Cancer Janus Kinase Inhibitor Manufacturing Plants Distribution
Table Cancer Janus Kinase Inhibitor Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Cancer Janus Kinase Inhibitor Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer Janus Kinase Inhibitor Production (K Pcs) of Major Manufacturers (2014-2019)
Table Cancer Janus Kinase Inhibitor Production Market Share of Major Manufacturers (2014-2019)
Figure Cancer Janus Kinase Inhibitor Production Share by Manufacturers in 2018
Table Cancer Janus Kinase Inhibitor Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Cancer Janus Kinase Inhibitor Revenue Market Share of Major Manufacturers (2014-2019)
Figure Cancer Janus Kinase Inhibitor Revenue Share by Manufacturers in 2018
Table Cancer Janus Kinase Inhibitor Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Cancer Janus Kinase Inhibitor Production by Regions 2014-2019 (K Pcs)
Table Global Cancer Janus Kinase Inhibitor Production Market Share by Regions 2014-2019
Figure Global Cancer Janus Kinase Inhibitor Production Market Share by Regions in 2018
Table Global Cancer Janus Kinase Inhibitor Revenue by Regions 2014-2019 (Million USD)
Table Global Cancer Janus Kinase Inhibitor Revenue Market Share by Regions 2014-2019
Figure Global Cancer Janus Kinase Inhibitor Revenue Market Share by Regions in 2018
Table Global Cancer Janus Kinase Inhibitor Consumption by Regions 2014-2019 (K Pcs)
Table Global Cancer Janus Kinase Inhibitor Consumption Market Share by Regions 2014-2019
Figure North America Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure North America Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table North America Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Europe Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure China Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure China Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table China Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Japan Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure India Cancer Janus Kinase Inhibitor Production Growth Rate 2014-2019 (K Pcs)
Figure India Cancer Janus Kinase Inhibitor Revenue Growth Rate 2014-2019 (Million USD)
Table India Cancer Janus Kinase Inhibitor Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Cancer Janus Kinase Inhibitor Market Share by Application (2014-2019)
Figure Global Value (Consumption) Cancer Janus Kinase Inhibitor Market Share by Application (2014-2019)
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Abbott Laboratories Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Abbott Laboratories Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Asana Biosciences Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Asana Biosciences Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Asana Biosciences Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Asana Biosciences Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Asana Biosciences Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Asana Biosciences Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Asana Biosciences Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Astra Zeneca Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Astra Zeneca Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Astra Zeneca Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astra Zeneca Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Astra Zeneca Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Astra Zeneca Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Astra Zeneca Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Dynamic Pharma Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Dynamic Pharma Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Eli Lilly Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Eli Lilly Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Eli Lilly Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Eli Lilly Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Eli Lilly Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Eli Lilly Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Gilead Sciences Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Gilead Sciences Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Gilead Sciences Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Gilead Sciences Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Gilead Sciences Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Gilead Sciences Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Gilead Sciences Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Incyte Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Incyte Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Incyte Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Incyte Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Incyte Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Incyte Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Incyte Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Product Introduction, Application and Specification
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Production Growth Rate (2014-2019)
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Production Market Share (2014-2019)
Figure Kyowa Hakko Cancer Janus Kinase Inhibitor Revenue Market Share (2014-2019)
Table Kyowa Hakko Cancer Janus Kinase Inhibitor Main Business and Markets Served
Table Moleculin Cancer Janus Kinase Inhibitor Production Sites and Area Served
Table Pfizer Cancer Janus Kinase Inhibitor Production Sites and Area Served
Figure Global Cancer Janus Kinase Inhibitor Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Cancer Janus Kinase Inhibitor Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Cancer Janus Kinase Inhibitor Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Cancer Janus Kinase Inhibitor Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Cancer Janus Kinase Inhibitor Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Cancer Janus Kinase Inhibitor by Type (2019-2025)
Table Global Consumption (K Pcs) of Cancer Janus Kinase Inhibitor by Application (2019-2025)
Table Cancer Janus Kinase Inhibitor Distributors List
Table Cancer Janus Kinase Inhibitor Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Abbott Laboratories、Asana Biosciences、Astra Zeneca、Celon Pharmaceuticals、Dynamic Pharma、Eli Lilly、Gilead Sciences、Hanmi Pharmaceuticals、Incyte、Kyowa Hakko、Moleculin、Pfizer、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがんヤヌスキナーゼ阻害剤市場(Global Cancer Janus Kinase Inhibitor Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp